Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Gen-Probe, a developer of nucleic acid diagnostics for human disease, has launched a bid to acquire Innogenetics, a Belgian molecular diagnostics firm, for $334 million. The offer competes with a deal announced in April by Solvay to acquire Innogenetics for about $280 million. Solvay currently owns 7% of Innogenetics. A Gen-Probe acquisition would create the world's largest stand-alone molecular diagnostics company, with annual sales in excess of $500 million, according to Gen-Probe. A Solvay official tells C&EN that the company "is currently analyzing the new situation and evaluating all the options."
This article has been sent to the following recipient: